Table 3.
Patients with single or two ulcers and their conditions during clinical follow-up after treatment with intralesional meglumine antimoniate. Data presented as frequencies (%).
Ulcer Conditions | First Month Post-Tx. | Third Month Post-Tx. | Sixth Month Post-Tx. | |
---|---|---|---|---|
Patient with a single ulcer n = 117 |
Healing | 53 (45) | 70 (60) | 85 (73) |
Partial reduction | 30 (26) | 13 (11) | - | |
Without changes | 2 (2) | 5 (4) | - | |
Increasing | 3 (3) | 1 (1) | - | |
Withdrawal | 1(1) | - | - | |
Therapeutic Failure | 2 (2) | 1 (1) | 5 (4) | |
No follow up | 26 (22) | 27 (23) | 27 (23) | |
Patients with two ulcers n = 35 |
Healing | 23 (66) | 29 (83) | 31 (89) |
Partial reduction | 7 (20) | 2 (6) | - | |
Without changes | 1(3) | - | - | |
Increasing | - | - | - | |
Withdrawal | - | - | - | |
Therapeutic Failure | - | - | 1 (3) | |
No follow up | 4 (11) | 4 (11) | 3 (9) |
Post-Tx.: post treatment. Dash (-): No recorded ulcers.